These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18324760)

  • 1. Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2.
    Mores A; Matziari M; Beau F; Cuniasse P; Yiotakis A; Dive V
    J Med Chem; 2008 Apr; 51(7):2216-26. PubMed ID: 18324760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of domain-selective angiotensin I-converting enzyme inhibitors.
    Redelinghuys P; Nchinda AT; Sturrock ED
    Ann N Y Acad Sci; 2005 Nov; 1056():160-75. PubMed ID: 16387685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors.
    Rella M; Rushworth CA; Guy JL; Turner AJ; Langer T; Jackson RM
    J Chem Inf Model; 2006; 46(2):708-16. PubMed ID: 16563001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structures of highly specific phosphinic tripeptide enantiomers in complex with the angiotensin-I converting enzyme.
    Masuyer G; Akif M; Czarny B; Beau F; Schwager SL; Sturrock ED; Isaac RE; Dive V; Acharya KR
    FEBS J; 2014 Feb; 281(3):943-56. PubMed ID: 24289879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the domain specificity of phosphinic inhibitors RXPA380 and RXP407 in angiotensin-converting enzyme.
    Kröger WL; Douglas RG; O'Neill HG; Dive V; Sturrock ED
    Biochemistry; 2009 Sep; 48(35):8405-12. PubMed ID: 19658433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure of testis angiotensin-converting enzyme in complex with the C domain-specific inhibitor RXPA380.
    Corradi HR; Chitapi I; Sewell BT; Georgiadis D; Dive V; Sturrock ED; Acharya KR
    Biochemistry; 2007 May; 46(18):5473-8. PubMed ID: 17439247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and metal binding of novel Pseudo- oligopeptides containing two phosphinic acid groups.
    Ye Y; Liu M; Kao JL; Marshall GR
    Biopolymers; 2008 Jan; 89(1):72-85. PubMed ID: 17910046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined use of selective inhibitors and fluorogenic substrates to study the specificity of somatic wild-type angiotensin-converting enzyme.
    Jullien ND; Cuniasse P; Georgiadis D; Yiotakis A; Dive V
    FEBS J; 2006 Apr; 273(8):1772-81. PubMed ID: 16623712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity.
    Papakyriakou A; Spyroulias GA; Sturrock ED; Manessi-Zoupa E; Cordopatis P
    Biochemistry; 2007 Jul; 46(30):8753-65. PubMed ID: 17605472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitors.
    Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4612-5. PubMed ID: 16784850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design.
    Corradi HR; Schwager SL; Nchinda AT; Sturrock ED; Acharya KR
    J Mol Biol; 2006 Mar; 357(3):964-74. PubMed ID: 16476442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymase.
    Greco MN; Hawkins MJ; Powell ET; Almond HR; de Garavilla L; Hall J; Minor LK; Wang Y; Corcoran TW; Di Cera E; Cantwell AM; Savvides SN; Damiano BP; Maryanoff BE
    J Med Chem; 2007 Apr; 50(8):1727-30. PubMed ID: 17361995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and molecular modeling of a lisinopril-tryptophan analogue inhibitor of angiotensin I-converting enzyme.
    Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4616-9. PubMed ID: 16784843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The importance of ACE2 in regulating the cardiovascular system].
    Raz A; Gamliel-Lazarovich A; Bogner I; Strigevsky A; Keidar S
    Harefuah; 2007 Sep; 146(9):703-6, 733. PubMed ID: 17969309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A synthetic method for diversification of the P1' substituent in phosphinic dipeptides as a tool for exploration of the specificity of the S1' binding pockets of leucine aminopeptidases.
    Vassiliou S; Xeilari M; Yiotakis A; Grembecka J; Pawełczak M; Kafarski P; Mucha A
    Bioorg Med Chem; 2007 May; 15(9):3187-200. PubMed ID: 17337192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship study between Ornithyl-Proline and Lysyl-Proline based tripeptidomimics as angiotensin-converting enzyme inhibitors.
    Pavar MC; Hanif K; Azam A; Lata S; Qadar Pasha MA; Pasha S
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2117-21. PubMed ID: 16464585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restriction of the in vitro formation of angiotensin II by leucinyl-arginyl-tryptophan, a novel peptide with potent angiotensin I-converting enzyme inhibitory activity.
    Wu J; Yuan L; Aluko RE
    Biosci Biotechnol Biochem; 2006 May; 70(5):1277-80. PubMed ID: 16717437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular basis for the selection of captopril cis and trans conformations by angiotensin I converting enzyme.
    Tzakos AG; Naqvi N; Comporozos K; Pierattelli R; Theodorou V; Husain A; Gerothanassis IP
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5084-7. PubMed ID: 16889963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domain-selective ligand-binding modes and atomic level pharmacophore refinement in angiotensin I converting enzyme (ACE) inhibitors.
    Tzakos AG; Gerothanassis IP
    Chembiochem; 2005 Jun; 6(6):1089-103. PubMed ID: 15883972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.